Latest filing published 15 Dec 2008 for BARR PHARMACEUTICALS INC, €366k.
Insider track record
No signal scores available.
Peter Seaver: trading record in brief
This profile gathers the share dealings of Peter Seaver in Barr Pharmaceuticals Inc. Over a trading history stretching from 2 December 2008 to 11 December 2008, the count stands at 69 filings.
Sales make up the whole of the open-market record (63 sales, €4.4M). The rest of the record consists of 6 option exercises.
Most recently, on 15 December 2008, the filings show an option exercise worth €366k in Barr Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Peter Seaver
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$48.84Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:0
- 10,000 shares@ US$39.76Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:1
- 3,300 shares@ US$65.00Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:2
- 3,000 shares@ US$65.01Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:3
- 400 shares@ US$65.01Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:4
- 900 shares@ US$65.01Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:5
- 300 shares@ US$65.01Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:6
- 200 shares@ US$65.02Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:7
- 3,700 shares@ US$65.02Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:8
- 100 shares@ US$65.03Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:9
- 700 shares@ US$65.03Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:10
- 500 shares@ US$65.04Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:11
- 1,200 shares@ US$65.04Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:12
- 300 shares@ US$65.05Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:13
- 900 shares@ US$65.05Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:14
- 200 shares@ US$65.06Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:15
- 600 shares@ US$65.07Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:16
- 700 shares@ US$65.08Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:17
- 600 shares@ US$65.11Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:18
- 200 shares@ US$65.12Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:19
- 200 shares@ US$65.15Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:20
- 400 shares@ US$65.17Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:21
- 300 shares@ US$65.18Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:22
- 300 shares@ US$65.19Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:23
- 1,000 shares@ US$65.22Barr Pharmaceuticals, Inc.SEC:0001209191-08-065849:24
25 of 69 declarations
